Trial Profile
A phase I study of AST-1753 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Apr 2015
Price :
$35
*
At a glance
- Drugs AST 1753 (Primary)
- Indications Staphylococcal infections
- Focus Adverse reactions
- 07 Apr 2015 New trial record